PT‑141 10mg

Within Europe this product is supplied including bacteriostatic water; outside Europe only the peptide vial is provided.

For research use only — not for human or veterinary use.

Product Overview

PT-141 is a synthetic melanocortin receptor–active peptide studied in controlled laboratory environments for its interaction with melanocortin signalling pathways and neuroendocrine regulatory systems. This lyophilized 10 mg preparation is supplied in a sealed research vial and supports reproducible in vitro experimentation.

Peptide Overview

PT-141 is derived from melanocortin-related peptide research and has been incorporated into laboratory models examining receptor-binding behaviour, signalling cascade activation and neuroendocrine pathway dynamics. Its defined structure and stability profile make it suitable for comparative peptide evaluation under controlled experimental conditions.

Historical Background and Scientific Context

Research into melanocortin receptor–active peptides expanded significantly during the late twentieth and early twenty-first centuries as laboratories investigated receptor-mediated signalling mechanisms involved in neuroregulatory communication systems. PT-141 has since been utilised in preclinical research frameworks studying receptor selectivity, pathway activation and signalling modulation.

Mechanistic Focus in Research

• Melanocortin receptor interaction analysis
• Neuroendocrine signalling pathway modelling
• Receptor-binding and activation dynamics
• Comparative structure–function evaluation
• Controlled in vitro biochemical investigations

Analytical Verification (COA)

Independent Liquilabs analysis confirms validation for Batch GF082025028. Key analytical results include:

• Assay Content: 11.88 mg
• Identification – Retention Time: 0.992
• Identification – Spectrum: 997
• Purity: 99 percent
• Endotoxin Level: 0.0120 EU per mg
• Total Aerobic Microbial Count: not detected
• Total Yeast and Mold Count: not detected
• Heavy Metals: not detected including arsenic, cadmium, cobalt, lead, nickel, mercury and vanadium

All analytical values were obtained using validated chromatographic, spectroscopic and microbiological procedures. Results relate only to the tested batch sample.

Research Applications

• Melanocortin receptor signalling research
• Neuroendocrine pathway modelling
• Receptor-interaction and activation studies
• Comparative peptide evaluation
• Controlled in vitro laboratory investigations

Grail Formula Quality

Every Grail Formula research peptide undergoes independent third-party laboratory testing for identity, assay accuracy, purity and microbial safety. Each batch is verified for analytical consistency and reproducibility to support reliable scientific research outcomes.

When You Choose Grail Formula…

Researchers receive fully documented peptide materials with batch-number traceability, sealed-vial integrity and transparent laboratory verification. EU shipments include sterile bacteriostatic water; outside the EU only the peptide vial is supplied.

Used solely for in vitro experiments and cannot be:

• Used in clinical trials involving humans
• Administered to humans as part of an experiment
• Supplied for human investigational use

Independently verified by Liquilabs s.r.o. (Czechia)
Validated assay content 11.88 mg
Confirmed purity 99 percent
Retention time and spectral identity confirmation
Endotoxin level 0.0120 EU per mg
No detectable microbial contamination
No detectable heavy metals
EU shipments include bacteriostatic water
For research use only — not for human or veterinary use

For laboratory research only. Not intended for human consumption, injection, or cosmetic use.

This product is for research purposes only. Not for human use or diagnostic/therapeutic applications. Keep out of reach of children.